Efficacy of intradermal hyaluronic acid plus polynucleotides in vulvovaginal atrophy: a pilot study

References

• Portman DJ, Gass ML. Vulvovaginal atrophy terminology consensus conference panel. Maturitas. 2014;79(3):349–354.
   PubMed Web of Science ®Google Scholar
• Kim HK, Kang SY, Chung YJ, et al. The recent review of the genitourinary syndrome of menopause. J Menopausal Med. 2015;21(2):65–71.
   PubMedGoogle Scholar
• Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010;85(1):87–94.
   PubMed Web of Science ®Google Scholar
• Moral E, Delgado JL, Carmona F, et al. Genitourinary syndrome of menopause: prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018;21(2):167–173.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3–9.
   PubMed Web of Science ®Google Scholar
• Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause. 2008;15(4 Pt 1):661–666.
   PubMed Web of Science ®Google Scholar
• Phillips NA, Bachmann GA. Genitourinary syndrome of menopause: common problem, effective treatments. Cleve Clin J Med. 2018;85(5):390–398.
   PubMed Web of Science ®Google Scholar
• Anglana F, Lippa P, Ronca S. Trattato di patologia vulvare. Con competenze ginecologiche, dermatologiche e psicologiche vol.III Dermatosi e Dermatiti non infettive – Patologia vulvare nella malattia da HIV; Ediz. SEE Firenze. https://www.medicalinformation.it/catalog/product/view/id/18306/s/trattato-di-patologiavulvare-vol-3-dermatosi-e-dermatiti-non-infettive-patologia-vulvare-nella-malattia-da-hiv-aids-anglanalippa-ronca/category/2204/
   Google Scholar
• The North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of the North american menopause society. Menopause. 2007;14:355–369.
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–522.
   PubMed Web of Science ®Google Scholar
• The North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North american menopause society. Menopause. 2013;20:888–902. quiz 3–4.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Gallo M, Gambacciani M, et al. Joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Società Italiana per la Menopausa (SIM) and the Società Italiana della Terza Età (SIGiTE). Minerva Ginecol. 2019;71(5):345–352.
   PubMed Web of Science ®Google Scholar
• Mariani L, Gadducci A, Vizza E, et al. Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy. Gynecol Endocrinol. 2013;29(1):25–29.
   PubMed Web of Science ®Google Scholar
• Biglia N, Bounous VE, D'Alonzo M, et al. Vaginal atrophy in breast cancer survivors: attitude and approaches among oncologists. Clin Breast Cancer. 2017;17(8):611–617.
   PubMed Web of Science ®Google Scholar
• Bell RJ, Rizvi F, Islam RM, et al. A systematic review of intravaginal testosterone for the treatment of vulvovaginal atrophy. Menopause. 2018;25(6):704–709.
   PubMed Web of Science ®Google Scholar
• Pelletier G, Ouellet J, Martel C, et al. Androgenic action of dehydroepiandrosterone (DHEA) on nerve density in the ovariectomized rat vagina. J Sex Med. 2013;10(8):1908–1914.
   PubMed Web of Science ®Google Scholar
• Sauer U, Talaulikar V, Davies MC. Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase. Maturitas. 2018;116:79–82.
   PubMed Web of Science ®Google Scholar
• Labrie F, Archer DF, Koltun W, et al. Moyneur É; members of the VVA Prasterone Research Group. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause. 2018;25(11):1339–1353.
   PubMed Web of Science ®Google Scholar
• Panjari M, Davis SR. Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas. 2011;70(1):22–25.
   PubMed Web of Science ®Google Scholar
• The North American Menopause Society. The 2012 hormone therapy position statement of: the North American menopause society. Menopause. 2012;19:257–271.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Xholli A, Venier M. Ospemifene in the management of vulvar and vaginal atrophy: focus on the assessment of patient acceptability and ease of use. Patient Prefer Adherence. 2020;14:55–62.
   PubMed Web of Science ®Google Scholar
• Palacios S. Ospemifene for vulvar and vaginal atrophy: an overview. Drugs Context. 2020;9:1–5.
   Google Scholar
• Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017;99:10–15.
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M, Russo E, et al. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric. 2018;21(2):148–152.
   PubMed Web of Science ®Google Scholar
• Dodero D, Frascani F, Angelucci M, et al. Solid state vaginal laser for the treatment of genitourinary syndrome of menopause: a preliminary report. Climacteric. 2018;08(02):113–121.
   Google Scholar
• Dodero D, Frascani F, Angelucci M, et al. Histological modifications of postmenopausal vaginal mucosa after regenerative solid state laser treatment: a multicenter study. Int J Womens Health Wellness. 2019;5(3):099.
   Google Scholar
• Lalji S, Lozanova P. Evaluation of the safety and efficacy of a monopolar nonablative radiofrequency device for the improvement of vulvo-vaginal laxity and urinary incontinence. J Cosmet Dermatol. 2017;16(2):230–234.
   PubMed Web of Science ®Google Scholar
• FDA warns against use of energy-based devices to perform vaginal ‘rejuvenation’ or vaginal cosmetic procedures: FDA Safety Communication. 2018; [cited 2018 Aug 1]. Available from: https://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm615013.htmlFDA.
   Google Scholar
• Preti M, Vieira-Baptista P, Digesu GA, et al. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS/ISSVD best practice consensus document. Neurourol Urodyn. 2019;38(3):1009–1023.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123:202–216.
   PubMed Web of Science ®Google Scholar
• Potter N, Panay N. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety. Climacteric. 2021;24(1):19–24.
   PubMed Web of Science ®Google Scholar
• Jin J, Sklar GE, Min Sen Oh V, et al. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269–286.
   PubMedGoogle Scholar
• Prestia VM, Bertozzi E, Radice M. Low-molecular weight hyaluronic acid for the treatment of vulvovaginal atrophy: an innovative clinical practice. IJMDAT 2020;3:e260.
   Google Scholar
• Dicker KT, Gurski LA, Pradhan-Bhatt S, et al. Hyaluronan: a simple polysaccharide with diverse biological functions. Acta Biomater. 2014;10(4):1558–1570.
   PubMed Web of Science ®Google Scholar
• Hong L, Shen M, Fang J, et al. Hyaluronic acid (HA)-based hydro gels for full-thickness wound repairing and skin regeneration. J Mater Sci Mater Med. 2018;29(9):150.
   PubMed Web of Science ®Google Scholar
• Stern R, Maibach HI. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. Clin Dermatol. 2008;26(2):106–122.
   PubMed Web of Science ®Google Scholar
• Jokar A, Davari T, Asadi N, Ahmadi F, Foruhari S. Comparison of the Hyaluronic Acid Vaginal Cream and Conjugated Estrogen Used in Treatment of Vaginal Atrophy of Menopause Women: A Randomized Controlled Clinical Trial. Int J Community Based Nurs Midwifery. 2016 Jan;4(1):69–78. PMID: 26793732; PMCID: P MC4709811.
   Google Scholar
• Dos Santos CCM, Uggioni MLR, Colonetti T, Colonetti L, Grande AJ, Da Rosa MI. Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review. J Sex Med. 2021 Jan;18(1):156–166.
   Google Scholar
• Colangelo MT, Govoni P, Belletti S, et al. Polynucleotide biogel enhances tissue repair, matrix deposition and organization. J Biol Regul Homeost Agents. 2021;35(1):355–362.
   PubMed Web of Science ®Google Scholar
• Thellung S, Florio T, Maragliano A, et al. Polydeoxyribonucleotides enhance the proliferation of human skin fibroblasts: involvement of A2 purinergic receptor subtypes. Life Sci. 1999;64(18):1661–1674.
   PubMed Web of Science ®Google Scholar
• Cavallini MB, Maioli E, Massirone L, et al. Consensus report on the use of PN‐HPT™ (polynucleotides highly purified technology) in aesthetic medicine. J Cosmet Dermatol. 2021;20(3):922–928.
   PubMed Web of Science ®Google Scholar
• Araco A, Araco F. Preliminary prospective and randomized study of highly purified polynucleotide vs placebo in treatment of moderate to severe acne scars. Aesthet Surg J. 2021;41(7):NP866–NP874.
   PubMed Web of Science ®Google Scholar
• Matera G, Dodici N, Raichi M. Improving on laser: biorevitalization of stretch marks, the polynucleotides infiltrations combined with CO2 laser option. Aesthet Med J. 2020;10:(4):380–395.
   Google Scholar
• Bachmann G. Urogenital ageing: an old problem newly recognized. Maturitas. 1995;22:S1–S5.
   PubMed Web of Science ®Google Scholar
• Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194.
   PubMed Web of Science ®Google Scholar
• Buzzaccarini G, Marin L, Noventa M, et al. Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review. Climacteric. 2021;24(6):560–512.
   PubMed Web of Science ®Google Scholar
• Hersant B, SidAhmed-Mezi M, Belkacemi Y, et al. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause. 2018;25(10):1124–1130.
   PubMed Web of Science ®Google Scholar
• Garavaglia E, Sala C, Busato M, et al. First use of thermal stabilized hyaluronic acid injection in one-year follow-up patients with genitourinary syndrome. Med Devices. 2020;13:399–410.
   Google Scholar
• González IP, Leibaschoff G, Esposito C, et al. Genitourinary syndrome of menopause and the role of biostimulation with non-cross-linked injectable hyaluronic acid plus calcium hydroxyapatite. J Biol Regul Homeost Agents. 2019;33(6):1961–1966.
   PubMed Web of Science ®Google Scholar
• Palmieri IP, Raichi M. Biorevitalization of postmenopausal labia majora, the polynucleotide/hyaluronic acid option, Available from: www.oatext.com.
   Google Scholar
• Vanelli R, Costa P, Rossi SM, et al. Efficacy of intra-articular polynucleotides in the treatment of knee osteoarthritis: a randomized, double-blind clinical trial. Knee Surg Sports Traumatol Arthrosc. 2010;18(7):901–907.
   PubMed Web of Science ®Google Scholar
• Dallari D, Sabbioni G, D, Piccolo N, et al. Efficacy of Intra-Articular polynucleotides associated with hyaluronic acid versus hyaluronic acid alone in the treatment of Knee osteoarthritis: a randomized, Double-Blind, controlled clinical trial. Clin J Sport Med. 2020;30(1):1–7.
   PubMed Web of Science ®Google Scholar
• Neill SM, Lewis FM, Tatnall FM, et al. British association of dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010;163(4):672–682.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao S, Li H, et al. Expression of galectin-7 in vulvar lichen sclerosus and its effect on dermal fibroblasts. Oncol Lett. 2018;16(2):2559–2564.
   PubMed Web of Science ®Google Scholar
• Anglana F, Lippa P, Ronca S. Trattato di patologia vulvare. Con competenze ginecologiche, dermatologiche e psicologiche vol.IV; Ediz. SEE Firenze. https://www.medicalinformation.it/catalog/product/view/id/18306/s/trattato-di-patologiavulvare-vol-3-dermatosi-e-dermatiti-non-infettive-patologia-vulvare-nella-malattia-da-hiv-aids-anglanalippa-ronca/category/2204/
   Google Scholar
• Salwowska NM, Bebenek KA, Żądło DA, et al. Physiochemical properties and application of hyaluronic acid: a systematic review. J Cosmet Dermatol. 2016;15(4):520–526.
   PubMed Web of Science ®Google Scholar
• Jabbour S, Kechichian E, Hersant B, et al. Labia majora augmentation: a systematic review of the literature. Aesthet Surg J. 2017;37(10):1157–1164.
   PubMed Web of Science ®Google Scholar